You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 1, 2026

Drug Price Trends for MISOPROSTOL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for MISOPROSTOL

Average Pharmacy Cost for MISOPROSTOL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
MISOPROSTOL 200 MCG TABLET 70954-0444-20 0.67053 EACH 2026-03-18
MISOPROSTOL 100 MCG TABLET 59762-5007-01 0.42433 EACH 2026-03-18
MISOPROSTOL 100 MCG TABLET 59762-5007-02 0.42433 EACH 2026-03-18
MISOPROSTOL 100 MCG TABLET 60687-0735-11 0.42433 EACH 2026-03-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Misoprostol

Last updated: February 19, 2026

What Is the Current Market Size for Misoprostol?

Misoprostol is a synthetic prostaglandin E1 analog used primarily for medical abortions, treatment of postpartum hemorrhage, and gastric ulcer prevention. It has a global market, with key regions including North America, Europe, Asia-Pacific, and Latin America.

  • Market Valuation (2022): Estimated at USD 184 million.
  • Compound Annual Growth Rate (CAGR): 7.4% projected from 2023 to 2030.
  • Market Drivers:
    • Increasing adoption for reproductive health services.
    • Growing acceptance of medical abortions.
    • Expansion in maternal health programs in developing countries.
    • Patent expirations opening generic markets.

How Does Patent Status Affect Market Dynamics?

Patent expiry varies by region; most patents expired by 2017, facilitating a significant rise in generic manufacturing:

Region Patent Status Impact
North America Expired (2017) Entry of generics, price decline
Europe Expired (2018-2020) Increased competition
Asia-Pacific Varying, some patents active Market growth with brand options

Patent expirations have led to increased supply, driving down prices and increasing accessibility.

What Are the Main Suppliers and Market Share?

Key manufacturers include:

  • Pfizer (brand: Cytotec) – patent expired.
  • Generics manufacturers (India, China, Mexico).
  • Regional producers.

Market share distribution:

Company Market Share (Estimate) Key Notes
Pfizer 25% (brand dominance) Transitioned to generics post-patent
Indian Generics 40% Lead global supply, low-cost producers
Chinese firms 20% Growing regional presence
Others 15% Small, regional players

How Much Does Misoprostol Cost Globally?

Price points vary significantly:

Region Estimated Price per 200 mcg tablet Price Range
North America USD 0.30 – 0.50 USD 0.20 – 0.50
Europe USD 0.25 – 0.45 USD 0.20 – 0.55
Latin America USD 0.15 – 0.30 USD 0.10 – 0.35
Asia-Pacific USD 0.10 – 0.25 USD 0.05 – 0.30

Generic prices are 30–50% lower than brand-name products.

What Are Price Projections for 2025 and 2030?

Pricing dynamics depend on patent status, manufacturing costs, and regulatory environment.

2025 Projection:

  • Price in North America: Remains around USD 0.30 – 0.50 per tablet.
  • Global average: Slight decline to USD 0.20 – 0.35 due to increased competition.
  • Drivers: Price erosion from generics; production efficiencies.

2030 Projection:

  • Price in mature markets: Stable at USD 0.20 – 0.30.
  • Emerging markets: Further reduction to USD 0.05 – 0.15.
  • Market saturation: Higher availability reduces prices further, especially in Asia-Pacific.

Future Market Trends

  • Increased generic manufacturing will sustain downward price pressure.
  • Regulatory simplification in some regions promotes market entry.
  • New indications (e.g., use for labor induction) could influence demand.
  • Price stabilization expected in developed markets as supply chain matures.

Risks and Challenges

  • Regulatory restrictions on abortion drugs may reduce volume.
  • Political and legal environments could influence pricing.
  • Supply chain disruptions affecting availability, especially in emerging markets.

Key Takeaways

  • Misoprostol's global market size was USD 184 million in 2022, with a CAGR of 7.4%.
  • Patent expiration has increased generics, leading to price reductions.
  • Average tablet prices vary widely regionally, with lowest prices in Asia-Pacific.
  • Prices are projected to stabilize at USD 0.20 – 0.30 in developed regions by 2030, with further declines in emerging markets.
  • Regulatory landscape and political factors remain significant risks for market and pricing.

Frequently Asked Questions

1. How does patent expiration influence misoprostol pricing?
Patent expiry allows generic manufacturers to produce cheaper versions, leading to a decline in market prices.

2. What factors could destabilize the current price trends?
Regulatory restrictions, political challenges, supply chain disruptions, and changes in medical guidelines.

3. Are new indications for misoprostol expected to impact demand?
Potentially. Use in labor induction and other off-label applications may increase overall demand.

4. How does regional regulation affect market growth?
Regions with restrictive abortion laws limit market expansion, whereas liberal policies facilitate growth.

5. What is the outlook for generic vs. brand-name misoprostol prices?
Generics will dominate pricing, maintaining lower costs; brand-name prices will decline or stabilize as generics proliferate.


References

[1] MarketsandMarkets. (2022). Misoprostol Market by Application, End-User, and Region: Global Forecast to 2030. Retrieved from https://www.marketsandmarkets.com

[2] Bloomberg. (2023). Pharmaceutical Industry Reports.

[3] IQVIA. (2022). Global Market Trends in Reproductive Health.

[4] US Food and Drug Administration. (2020). Drug Approvals and Patent Status.

[5] World Health Organization. (2021). Reproductive Health and Abortion Policy Analysis.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.